Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

• Status: Completed
• Trial end date: 2020-03-23
• Target enrollment: 0
• Participant gender: Male

Summary

To evaluate the safety and pharmacokinetics drug-drug interaction of YYC506-T and YYC506-A

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yooyoung Pharmaceutical Co., Ltd.

Criteria

Inclusion Criteria:

• Over 19 ages healty men

• Over 50.0kg, 18.0kg/m2 ≤ BMI ≤30.0kg/m2

• Men who dont have congenital disease and other cronic disease need to be cared etc.

Exclusion Criteria:

• Men who have congenital liver disease (AST, ALT, CK ≥ 2X ULN)

• Men who have drunken or eatten something including carffeine within 24 hours before etc.